Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)

Pizzagalli, Diego A.Smoski, MoriaAng, Yuen-SiangWhitton, Alexis E.Sanacora, GerardMathew, Sanjay J.Nurnberger, John, Jr.Lisanby, Sarah H.Iosifescu, Dan V.Murrough, James W.Yang, HongqiuWeiner, Richard D.Calabrese, Joseph R.Goodman, WaynePotter, William Z.Krystal, Andrew D.2024-08-202024-08-202021Pizzagalli DA, Smoski M, Ang YS, et al. Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS). Neuropsychopharmacology. 2021;46(12):2224. doi:10.1038/s41386-021-01145-9https://hdl.handle.net/1805/42854Correction to: Neuropsychopharmacology 10.1038/s41386-020-0738-4, published online 16 June 2020 In this article a conflict of interest was missing. The co-author Sanjay J. Mathew served as a consultant to Alkermes. The original article has been corrected. The original article can be found online at 10.1038/s41386-020-0738-4.en-USPublisher PolicyOpioid analgesicsAnxietyAnxiety disordersBayes TheoremNarcotic antagonistsCorrection to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)Article